To Study the effects of Unani formulation Habb e Mujarrab in patients with Migraine without aura

A Study to Evaluate the Safety and Efficacy of Habb -e-Mujarrab in the Management of Migraine (Shaqiqa) without Aura: A Randomized single blind with standard control study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/050748

Enrollment

Registered

2023-03-16

Start date

Unknown

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

Intervention1: Habb e Mujarrab: It is a classical Unani formulation taken from NFUM part IV and Unani classical textbook Al Qarabadene.The formulation comprises of 1 part of each Sibr (Aloe barbeden

Eligibility

Inclusion criteria

Inclusion criteria: 1)Clinically diagnosed patient of Migraine without aura according to ICHD criteria. 2)Patients in age group of 18 to 65 years. 3)Irrespective of gender. 4)Patients, who are ready to sign the informed consent, follow the protocol and willing to participate in clinical study voluntarily 5)Willing to complete daily diary.

Exclusion criteria

Exclusion criteria: 1)Patients below 18 years and above 65 years. 2)Patient who fail to follow up. 3)Patient who fail to give written consent. 4)Patient with known History Brain Tumors, Epilepsy, Stroke, Depression, Anxiety. 5)Patients suffering from systemic illnesses like, Diabetes Mellitus, Uncontrolled Hypertension, Malignancy, Liver and Kidney dysfunction. 6)Pregnant and lactating mother.

Design outcomes

Primary

Measure	Time frame
1)GAMS scale (Global assessment of migraine severity) 2)MIDAS scale (Migraine disability assessment scale) 3)Headache frequency (From daily headache diary) Timepoint: 45 Days	—

Secondary

Measure	Time frame
A. At least five attacks fulfilling criteria B-D B. Headache attacks lasting 4-72 hours (untreated or successfully treated) C. Headache has at least two of the following four characteristics. 1. Unilateral location 2. Pulsating quality 3. Moderate or severe pain intensity Aggravation by or causing avoidance of routine physical activity (e.g., walking or climbing stairs) D. During headache at least one of the following 1.Nausea and/or vomiting 2.Photophobia and phonophobia E. Not attributed to another disorder Timepoint: 45 Days	—

Measure

Time frame

A. At least five attacks fulfilling criteria B-D B. Headache attacks lasting 4-72 hours (untreated or successfully treated) C. Headache has at least two of the following four characteristics. 1. Unilateral location 2. Pulsating quality 3. Moderate or severe pain intensity Aggravation by or causing avoidance of routine physical activity (e.g., walking or climbing stairs) D. During headache at least one of the following 1.Nausea and/or vomiting 2.Photophobia and phonophobia E. Not attributed to another disorder Timepoint: 45 Days

—

Countries

India

Contacts

Public ContactDr Zaffar Hussain

Regional Research Institute of Unani Medicine (RRIUM) Srinagar

hussainzaffar6@gmail.com7006021996

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026